| Nov 7 |
Why Lyft Shares Are Trading Higher By Over 21%; Here Are 20 Stocks Moving Premarket
|
| Nov 4 |
Sutro Biopharma Demonstrates Meaningful ADC Innovation with Five Presentations at the 15th Annual World ADC Conference
|
| Nov 4 |
Sutro Biopharma begins trial of acute myeloid leukaemia treatment in children
|
| Nov 1 |
Sutro Biopharma Announces Initiation of the Registration-enabling REFRαME-P1 Trial with Luvelta for Pediatric Patients with CBF/GLIS AML
|
| Oct 20 |
Sutro Biopharma (NASDAQ:STRO) shareholders have endured a 80% loss from investing in the stock three years ago
|
| Oct 15 |
Sutro Biopharma: Post ESMO Selloff, Does Their Strategy In FRα Remain Viable?
|
| Oct 10 |
Sutro Biopharma Highlights Next-Generation ADC Innovation and Near-term Pipeline at Research Forum
|
| Sep 23 |
Sutro Biopharma's Competitive ADCs Position It For Future Growth In Oncology
|
| Sep 20 |
Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
| Sep 14 |
Sutro Biopharma Announces Updated Data from Phase 1b Study of Luvelta in Combination with Bevacizumab at ESMO 2024
|
